4.7 Review

Tumor Molecular Imaging with Nanoparticles

Journal

ENGINEERING
Volume 2, Issue 1, Pages 132-140

Publisher

ELSEVIER
DOI: 10.1016/J.ENG.2016.01.027

Keywords

Tumor; Molecular imaging; Nanoparticles

Ask authors/readers for more resources

Molecular imaging (MI) can provide not only structural images using traditional imaging techniques but also functional and molecular information using many newly emerging imaging techniques. Over the past decade, the utilization of nanotechnology in MI has exhibited many significant advantages and provided new opportunities for the imaging of living subjects. It is expected that multimodality nanoparticles (NPs) can lead to precise assessment of tumor biology and the tumor microenvironment. This review addresses topics related to engineered NPs and summarizes the recent applications of these nanoconstructs in cancer optical imaging, ultrasound, photoacoustic imaging, magnetic resonance imaging (MRI), and radionuclide imaging. Key challenges involved in the translation of NPs to the clinic are discussed. (C) 2016 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Radiology, Nuclear Medicine & Medical Imaging

23Na-MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis

Linda Osei Poku, Yongna Cheng, Kai Wang, Xilin Sun

Summary: The regulation of sodium ion influx and efflux in cells plays a crucial role in cell function and cancer metastasis. Changes in sodium ion concentration could serve as a potential biomarker for cancer diagnosis and prognosis. Na-23-MRI technology shows promise in noninvasive in vivo assessment of cancer therapy and monitoring of cancer immunotherapy.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2021)

Review Nanoscience & Nanotechnology

Update on the development of molecular imaging and nanomedicine in China: Optical imaging

Lina Wu, Hongyan Zou, Hongbin Wang, Sihang Zhang, Shuang Liu, Ying Jiang, Jing Chen, Yingbo Li, Mengping Shao, Ruixin Zhang, Xiaona Li, Jing Dong, Lili Yang, Kai Wang, Xinyuan Zhu, Xilin Sun

Summary: Molecular imaging has gained global attention, with Chinese scientists contributing to impactful research through national programs and international collaborations, providing innovative solutions to unmet medical needs in the field.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)

Article Chemistry, Multidisciplinary

Synthesis of MoSe2/CoSe2 Nanosheets for NIR-Enhanced Chemodynamic Therapy via Synergistic In-Situ H2O2 Production and Activation

Yang Li, Ran Jia, Huiming Lin, Xilin Sun, Fengyu Qu

Summary: The MoSe2/CoSe2@PEG nanosheets can generate H2O2 in tumors, elevate the intracellular H2O2 level, and have great potential in anticancer applications.

ADVANCED FUNCTIONAL MATERIALS (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers

Zhaoguo Han, Mingxing Ke, Xiang Liu, Jing Wang, Zhengqi Guan, Lina Qiao, Zhexi Wu, Yingying Sun, Xilin Sun

Summary: Precision medicine plays a crucial role in cancer therapy by providing individualized treatment plans to improve efficacy and minimize side effects. Molecular imaging, as a noninvasive tool, can detect tumor biology features and provide valuable information for guiding cancer precision medicine, such as treatment targets and response evaluation.

MOLECULAR IMAGING AND BIOLOGY (2022)

Article Chemistry, Multidisciplinary

Pulmonary Delivery of Theranostic Nanoclusters for Lung Cancer Ferroptosis with Enhanced Chemodynamic/Radiation Synergistic Therapy

Yingbo Li, Jie Yang, Guangying Gu, Xu Guo, Chunbo He, Jiemei Sun, Hongyan Zou, Hongbin Wang, Shuang Liu, Xiaona Li, Shujun Zhang, Kai Wang, Lili Yang, Ying Jiang, Lina Wu, Xilin Sun

Summary: Smart nanoclusters can enhance therapy efficacy of lung cancer by increasing drug penetration and providing superior antitumor effects. pH-sensitive superparamagnetic iron oxide nanoclusters disintegrate into smaller particles and release more iron ions in an acidic microenvironment, which enhance tumor ferroptosis and apoptosis with radiotherapy and chemodynamic therapy.

NANO LETTERS (2022)

Article Chemistry, Physical

Magnetic Resonance/Infrared Dual-Modal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy Nanoplatform Based on Cu1.96S-Gd@FA for Precision Cancer Theranostics

Lixin Cheng, Dongmiao Sang, Fangyu Zhao, Lili Yang, Zhilin Guo, Xinfeng Zhang, Qiaoqiao Yang, Wenju Qiao, Xiaohong Sun, Xiaohong Guan, Haoyu Wang, Jiannan Wang, Hongyan Zou, Xiu'e Li, Fang Fang, Yang Li, Shujun Zhang, Lina Wu, Huiming Lin, Xilin Sun, Kai Wang

Summary: This study developed Gd-surface functionalized copper sulfide nanoparticles modified with folic acid for efficient synergistic photothermal/photodynamic therapy. The nanoparticles showed high longitudinal relaxivity, strong photothermal conversion efficiency, and enhanced reactive oxygen species production. The targeted Cu1.96S-Gd@FA nanoparticles exhibited higher signal enhancement for magnetic resonance and could be visualized in infrared imaging. Additionally, the nanoparticles showed biodegradation behavior and good drug elimination performance.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2022)

Article Chemistry, Multidisciplinary

An Osimertinib-Perfluorocarbon Nanoemulsion with Excellent Targeted Therapeutic Efficacy in Non-small Cell Lung Cancer: Achieving Intratracheal and Intravenous Administration

Jie Yang, Yingbo Li, Jiemei Sun, Hongyan Zou, Yige Sun, Jing Luo, Qian Xie, A. Rong, Hongbin Wang, Xiaona Li, Kai Wang, Lili Yang, Teng Ma, Lina Wu, Xilin Sun

Summary: Low accumulation of anticancer drugs in tumors and serious systemic toxicity are still major challenges in pharmaceuticals. Pulmonary delivery of nanoscale-based drug delivery systems offers a strategy to increase antitumor activity with minimal adverse exposure. In this study, we report an osimertinib-loaded nanoemulsion system that synergizes with F-19 MRI-guided LIFU for lung cancer therapy. The research validates the potential of this nanoemulsion system for lung cancer treatment, achieving quick distribution and drug release without severe side effects.

ACS NANO (2022)

Article Biochemistry & Molecular Biology

Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC

Yige Sun, Jie Yang, Yingbo Li, Jing Luo, Jiemei Sun, Daoshuang Li, Yuchen Wang, Kai Wang, Lili Yang, Lina Wu, Xilin Sun

Summary: The study developed a multirooted delivery system INC280-PFCE nanoparticles (NPs) for improving MET-targeted therapy in NSCLC patients with liver metastases. The NPs demonstrated excellent antitumor ability in vitro and real-time MRI visualization of sustained release and prolonged retention behaviors within tumors. These results suggest high efficacy and biocompatibility of NPs after a single low-dose administration.

MOLECULAR CANCER (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain

Xuefeng Yan, Fabrice G. Simeon, Jeih-San Liow, Cheryl L. Morse, Jose A. Montero Santamaria, Madeline Jenkins, Lester S. Manly, Maia Van Buskirk, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis, Paolo Zanotti-Fregonara

Summary: This study assessed the ability of [F-18]SF51 to quantify TSPO in rhesus monkey brain. The results demonstrate that [F-18]SF51 is an excellent radioligand that can quantify TSPO with a good ratio of specific to nondisplaceable uptake and has minimal radiometabolite accumulation in brain. These findings suggest that [F-18]SF51 should be further evaluated in humans.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Article Chemistry, Multidisciplinary

Porous Molybdenum Nitride Nanosphere as Carrier-Free and Efficient Nitric Oxide Donor for Synergistic Nitric Oxide and Chemo/Sonodynamic Therapy

Qingchen Bai, Miao Wang, Jingwei Liu, Xilin Sun, Piaoping Yang, Fengyu Qu, Huiming Lin

Summary: Given its physiological functions, nitric oxide (NO) has potential as a cancer therapy. This study utilizes a transition metal nitride MoN@PEG as an efficient NO donor, which releases NO specifically to the tumor microenvironment. The MoN@PEG also serves as a peroxidase and sonosensitizer, enhancing the anticancer treatment. The improved MoN-Pt@PEG enhances the sonodynamic therapy effect for generating more reactive oxygen species and facilitating in situ peroxynitrite generation. This work not only brings efficient antitumor effects but also expands the application of NO therapy.

ACS NANO (2023)

Review Nanoscience & Nanotechnology

Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: Recent advances and future prospects

A. Rong, Zhaoguo Han, Tianyi Wang, Mengyuan Zhu, Meifang Zhou, Xilin Sun

Summary: Lung cancer is a disease with high incidence and mortality rate, mainly due to limited efficacy of therapeutic drugs and insufficient drug delivery to the lungs. Nanoparticles pulmonary delivery techniques offer a new approach for precise diagnosis and treatment of lung cancer.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

First-in-Human Evaluation of 18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B

Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, Xuefeng Yan, Maia G. Van Buskirk, Madeline D. Jenkins, Jose A. Montero Santamaria, Kevin P. Maresca, Akihiro Takano, Jeih-San Liow, Thomas A. Chappie, Andrea Varrone, Sangram Nag, Lei Zhang, Zoe A. Hughes, Christopher J. Schmidt, Shawn D. Doran, Andrew Mannes, Paolo Zanotti-Fregonara, Maarten Ooms, Cheryl L. Morse, Sami S. Zoghbi, Christer Halldin, Victor W. Pike, Robert B. Innis

Summary: This study evaluated the properties of a newly developed selective PDE4B radioligand in the brains of rodents, monkeys, and humans. The results showed that the radioligand could quantify PDE4B in the human brain reasonably well, and it has the potential to be used in clinical studies.

JOURNAL OF NUCLEAR MEDICINE (2022)

Correction Materials Science, Biomaterials

Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer (vol 9, pg 443, 2021)

Lili Yang, Shanshan Liu, Jingjing Chu, Shuang Miao, Kai Wang, Qingwei Zhang, Yingyi Wang, Yadi Xiao, Lina Wu, Yang Liu, Longjian Yu, Caihong Yu, Xiang Liu, Mingxing Ke, Zhen Cheng, Xilin Sun

Summary: This article is a correction of the study on novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer. The authors have made a series of corrections to rectify the previously published errors.

BIOMATERIALS SCIENCE (2022)

Article Surgery

Pathophysiological mechanisms of ALPPS: experimental model

Ruifeng Wang, Zhen Quan, Tongsen Zheng, Kai Wang, Yang Liu, Zhaoguo Han, Xiance Wang, Shiling Ma, Lianxin Liu, Wan Yee Lau, Xilin Sun

Summary: This study used multiple imaging methods to assess the pathophysiological mechanisms of the future liver remnant (FLR) and tumors after the first stage of ALPPS. Changes in tumor volume, metabolism, and hemodynamics were observed. Molecular and functional imaging are promising non-invasive methods for investigating the pathophysiological mechanisms of ALPPS.

BRITISH JOURNAL OF SURGERY (2022)

Article Materials Science, Biomaterials

Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer

Lili Yang, Shanshan Liu, Jingjing Chu, Shuang Miao, Kai Wang, Qingwei Zhang, Yingyi Wang, Yadi Xiao, Lina Wu, Yang Liu, Longjian Yu, Caihong Yu, Xiang Liu, Mingxing Ke, Zhen Cheng, Xilin Sun

Summary: EGFR-targeted F-MPG and OH-MPG exhibit promising anti-tumor activity in NSCLC treatment with limited liver damage, making them promising drug candidates for further investigation in combating the deadly NSCLC.

BIOMATERIALS SCIENCE (2021)

No Data Available